Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
STLE Annual MeetingSTLE Annual Meeting
Not Confirmed
Not Confirmed
18-22 May, 2025
Not Confirmed
Not Confirmed
19-22 May, 2025
Not Confirmed
Not Confirmed
20-22 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
STLE Annual MeetingSTLE Annual Meeting
Industry Trade Show
Not Confirmed
18-22 May, 2025
Industry Trade Show
Not Confirmed
19-22 May, 2025
Industry Trade Show
Not Confirmed
20-22 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions
30 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mabwell-releases-6-study-results-of-innovative-drugs-and-platforms-at-the-2025-aacr-annual-meeting-302442007.html
24 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mabwell-to-present-clinical-data-of-9mw2821-combined-with-toripalimab-in-patients-with-uc-in-an-oral-presentation-at-2025-asco-302437147.html
02 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mabwell-announces-nmpa-approval-to-initiate-clinical-trial-of-novel-b7-h3-targeting-adc-for-advanced-solid-tumors-in-combination-with-pd-1-inhibitor-302418308.html
26 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mabwell-to-present-results-of-6-studies-at-the-2025-american-association-for-cancer-research-aacr-annual-meeting-302411590.html
09 Jan 2025
// CONTRACTPHARMA
https://www.contractpharma.com/breaking-news/mabwells-9mw2821-receives-breakthrough-therapy-designation-in-china-for-urothelial-cancer/
09 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mabwells-nectin-4-targeted-adc-9mw2821-combination-therapy-demonstrates-87-5-orr-and-granted-cde-breakthrough-therapy-designation-302346989.html
ABOUT THIS PAGE